Expression of cyclin A in Merkel cell carcinoma

APMIS

Volumn 112, Issue 1, 2004, Pages 39-44

  Koljonen, Virve ^a,c   Tukiainen, Erkki ^a   Haglund, Caj ^a   Böhling, Tom ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Toolo Hospital   (Finland)

Author keywords

Cyclin A; Immunohistochemistry; Merkel cell carcinoma; Primary neuroendocrine carcinoma of the skin; Prognostic factors

Indexed keywords

CYCLIN A;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MERKEL CELL TUMOR; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SKIN METASTASIS; STATISTICAL ANALYSIS; SUBCUTANEOUS TISSUE; TISSUE FIXATION; TISSUE SECTION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; CYCLIN A; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 1542329212     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm1120107.x     Document Type: Article

References (25)

1. Pan D, Naryan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and review of 110 new cases. Plast Reconstr Surg 2002;110:1259-65.
2. Chuang TY, Su WP, Muller SA. Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol 1990;23(2 Pt 1):254-6.
3. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999;21:16-20.
4. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneus neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315-23.
5. Koljonen V, et al. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003;29:607-10.
6. Tai PTH, et al. Merkel cell carcinoma of the skin. J Cutan Med Surg 2000;4:186-95.
7. Gollard R, et al. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000;88:1842-51.
8. Yam CH, Fung TK, Poon RYC. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 2002;59:1317-26.
9. Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci 2001;58:1907-22.
10. Obaya AJ, Sedivy M. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 2002;59:126-42.
11. Furihata M, et al. Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 1996;2:1781-5.
12. Kyushima N, et al. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 2002.
13. Volm M, et al. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 1997;75:1774-8.
14. Noguchi T, et al. Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am J Pathol 2000;156:2135-47.
15. Michalides R, et al. Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br J Cancer 2002;86:402-8.
16. Chen HM, et al. Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol 2003;39:476-82.
17. Huuhtanen RL, et al. A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients. Br J Cancer 1999;81:1017-21.
18. Florenes VA, et al. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol 2001;195:530-6.
19. Tran TA, et al. Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions. Hum Pathol 1998;29:1085-90.
20. Cheuk W, et al. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001;125:228-31.
21. Huuhtanen RL, et al. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res 1999;59:2885-90.
22. Michels JJ, et al. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance. Cancer 2003;97:1376-86.
23. Tang L, et al. Expression of cell cycle regulators in human cutaneous malignant melanoma. Melanoma Res 1999;9:148-54.
24. Tai PT, et al. Merkel cell carcinoma of the skin. J Cutan Med Surg 2000;4:186-95.
25. Brissett AE, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck 2002;24:982-8.